Author:
de Lange S. M.,van der Born K.,Kroep J. R.,Jensen H. A.,Pfeiffer P.,Cleverly A.,van Groeningen C. J.,Peters G. J.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference22 articles.
1. Abratt RP, Sandler A, Crino L et al (1998) Combined cisplatin and gemcitabine for non-small cell lung cancer: influence of scheduling on toxicity and drug delivery. Semin Oncol 25:35–43
2. Bergman AM, Pinedo HM, Peters GJ (2002) Determinants of resistance to 2',2'–difluorodeoxycytidine (gemcitabine). Drug Res Updates 5:19–33
3. Borner MM, Schöffski P, De Wit R et al (2002) Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomized crossover trial in advanced colorectal cancer. Eur J Cancer 38:349–358
4. Boublil JL, Milano G, Khater R et al (1985) Continuous 5-day regional chemotherapy by 5–fluorouracil in colon carcinoma: pharmacokinetic evaluation. Br J Cancer 52:15–20
5. Brown H, Prescott R (1999) Applied mixed models in medicine. Wiley, Chichester, UK
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献